Position in TXMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$253
+$21 QoQ
Shares Held
115
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 45 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TXMD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. TXMD ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in TXMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253 | 115 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $232 | 115 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $60 | 37 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $39 | 37 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $66 | 57 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $53 | 57 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $83 | 97 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $239 | 144 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $275 | 171 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $610 | 267 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $719 | 320 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $995 | 330 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,462 | 355 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,528 | 408 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,280 | 408 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,225 | 486 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,288 | 431 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $104,899 | 276,051 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $144,399 | 401,111 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $565,943 | 764,790 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $340,395 | 286,047 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $152,321 | 113,674 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $645,120 | 533,159 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $259,399 | 164,177 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $307,056 | 245,646 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $229,921 | 216,908 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||